Kronos Bio Inc reports results for the quarter ended in March - Earnings Summary

Kronos Bio

12/05/2021 24:14

* Kronos Bio Inc  KRON.OQ  reported a quarterly adjusted loss
of 48 cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 43 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Kronos Bio Inc's reported EPS for the quarter was a loss of 48
cents​.
* The mean earnings estimate of analysts had risen by
about 23.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Kronos Bio Inc shares had fallen by 14.4% this quarter and
lost 16.1% so far this year.
* The company reported a quarterly loss of $26.09 million.
* Wall Street's median 12-month price target for Kronos Bio Inc
is $47.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 11 at 11:14 p.m. GMT.
​All figures in US dollars